22NW, LP
- SEC CIK
- 0001694297
- Latest filing
- Aug 14, 2026
ANEB holding history
Anebulo Pharmaceuticals, Inc. in every 13F filed by 22NW, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANEB overviewAll 13F holders of ANEBFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −15,467,300−100.0% | Sold out | Holders |
| Q4 2025 | 15,467,300 | – | – | 00.0% | Unchanged | Holders |
| Q3 2025 | 15,467,300 | $38.7M | 20.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 15,467,300 | $22.3M | 16.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 15,467,300 | $20.1M | 13.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 15,467,300 | $26.0M | 16.4% | +10,101,010+188.2% | Added | Holders |
| Q3 2024 | 5,366,290 | $10.4M | 8.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5,366,290 | $14.6M | 12.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5,366,290 | $15.4M | 13.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 5,366,290 | $13.0M | 8.5% | +300,000+5.9% | Added | Holders |
| Q3 2023 | 5,066,290 | $15.5M | 11.5% | 00.0% | Unchanged | Holders |
| Q2 2023 | 5,066,290 | $11.9M | 7.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 5,066,290 | $14.7M | 9.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 5,066,290 | $12.3M | 6.6% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,066,290 | $14.2M | 8.0% | +1,703,577+50.7% | Added | Holders |
| Q2 2022 | 3,362,713 | $17.5M | 9.3% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3,362,713 | $23.8M | 8.6% | 00.0% | Unchanged | Holders |
| Q4 2021 | 3,362,713 | $20.7M | 6.4% | +19,148+0.6% | Added | Holders |
| Q3 2021 | 3,343,565 | $21.9M | 6.5% | 00.0% | Unchanged | Holders |
| Q2 2021 | 3,343,565 | $22.8M | 6.1% | +3,343,565 | New | Holders |